Passive protection of mice against infection with Trypanosoma cruzi with plasma: the use of blood- and vector bug-derived trypomastigote challenge.
A study was made of the protective effects of plasma (CMP) from mice convalescent from infection with Trypanosoma cruzi. A single dose of CMP was injected into mice infected with blood trypomastigotes of 1 of each of 5 strains of T. cruzi. Protection was greatest with strains BG, M1 and Y, and least with strain Peru. Strain Tulahuen was of intermediate susceptibility. The protective effect of CMP was found to be similar in mice infected by metacyclic trypomastigotes harvested from vector bugs and mice infected by blood trypomastigotes. Plasma (IMP) from mice hyperimmunized with 6 doses of a killed T. cruzi epimastigote vaccine with saponin as an adjuvant gave no protection against challenge with strain Y, although a group of mice hyperimmunized in parallel with those from which IMP was taken were strongly resistant to challenge.
D000818:Animals; D001769:Blood / Q000276:immunology*; D014355:Chagas Disease / Q000276:immunology*; D007112:Immunity, Maternally-Acquired; D007114:Immunization; D007116:Immunization, Passive; D008297:Male; D051379:Mice; D014349:Trypanosoma cruzi / Q000276:immunology*; D014612:Vaccines / Q000276:immunology
D014612:Vaccines